
Over 1 Million Drug-Resistant Infections Went Untreated Across LMICs
A new modeling study has found that only 6.9% of carbapenem-resistant Gram-negative (CRGN) bacterial infections received appropriate treatment in 2019 across eight low- and middle-income countries (LMICs). The analysis, led by Anant Mishra and colleagues, …